MarketWatch: E2 (Endovascular Engineering) Raises $80 Million Series C to Advance Next-Generation Thrombectomy Platform as Pulmonary Embolism Treatment Evolves Gilde Healthcare and Norwest co-led round to commercialize the Hēlo (R) Thrombectomy Platform ... E2 (Endovascular Engineering) Raises $80 Million Series C to Advance Next-Generation Thrombectomy Platform as Pulmonary Embolism Treatment Evolves MarketWatch: InterVene Completes First 30 Cases Using the Recana(R) Thrombectomy Catheter System, Plans for Broader Commercial Launch InterVene, Inc., a privately held medical device company advancing interventional care for venous disease, today announced the successful completion of 30 cases using the Recana(R) Thrombectomy ... InterVene Completes First 30 Cases Using the Recana(R) Thrombectomy Catheter System, Plans for Broader Commercial Launch Fierce Biotech: E2 lands $80M series C for next gen thrombectomy treatment The funding round follows high-profile acquisitions by Boston Scientific and Stryker to pick up mechanical thrombectomy devices for blood clot removal.
MedPage Today on MSN: First telerobotic thrombectomy; abnormal cholesterol in kids; donated heart quirks TCTMD: Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI The use of manual aspiration thrombectomy in primary PCI for STEMI has declined significantly since 2011, according to a new analysis of National Cardiovascular Data Registry (NCDR) CathPCI numbers. Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI Intravenous tenecteplase (TNKase) before endovascular thrombectomy improved outcomes for acute ischemic stroke patients who presented within 4.5 hours after onset in a randomized trial from China. The ... MedPage Today: Thrombectomy Led to Fewer Deaths in Patients With Acute Stroke and a Large Infarct In patients with acute stroke and a large infarct of unrestricted size, thrombectomy and medical care led to better functional outcomes and lower mortality compared with medical care alone, the ...
thrombectomy, Thrombectomy Led to Fewer Deaths in Patients With Acute Stroke and a Large Infarct TCTMD: TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year Performing manual thrombectomy routinely prior to primary PCI in STEMI patients does not reduce the composite of CV death, HF, recurrent MI or cardiogenic shock at 1 year, according to data from the ... Yahoo Finance: InterVene Completes First 30 Cases Using the Recana® Thrombectomy Catheter System, Plans for Broader Commercial Launch InterVene, Inc., a privately held medical device company advancing interventional care for venous disease, today announced the successful completion of 30 cases using the Recana® Thrombectomy Catheter ... InterVene Completes First 30 Cases Using the Recana® Thrombectomy Catheter System, Plans for Broader Commercial Launch
